Related Experiment Video
Updated: Aug 18, 2026

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever
Uma Sekar1, Padma Srikanth, Anupma Jyoti Kindo
1Department of Microbiology, Sri Raniachandra Medical College & Research Institute Porur, Chennai.
Abstract:
Multidrug resistance among Salmonella typhi is well known. Reports of treatment failure in enteric fever with Ciprofloxacin made us undertake this study to determine the antibiotic susceptibility pattern of S. typhi and S. paratyphi A isolated from typhoid bacteremia cases, by disc diffusion and MIC by broth dilution method. A total of 50 strains were tested, 48 of Salmonella typhi and 2 of S. paratyphi A. The disc diffusion method was done using ampicillin, chloramphenicol, cotrimoxazole, tetracycline, ciprofloxacin, ofloxacin, cefuroxime and ceftriaxone as antibiotics. The MIC was performed using ciproloxacin, ofloxacin and ceftriaxone based on standard procedure. ACCOT resistance as determined by disc diffusion method was seen in 68% of isolates. All the strains remained susceptible to flouroquinolones cephalosporins and aminoglycosides. The MIC of ciprofloxacin, ofloxacin and ceftriaxone were in the recommended range of susceptibility as given by NCCLS, 14 (28%) strains had MIC of ciprofloxacin greater than 0.5 ug/ml with 4 strains having an MIC of 1.56 ug/ml; 25 (50%) strains had MIC of ofloxacin greater than 0.5 ug/ml and 20 (40%) strains had MIC of ceftriaxone greater than 0.5 ug/ml. The high levels of MIC of ciprofloxacin may account for treatment failure cases. The rising levels of MIC of ofloxacin and ceftriaxone in S. typhi and S. paratyphi is also of concern. We document here the emergence of high levels of MIC not only to ciprofloxacin, but also ofloxacin and ceftriaxone in S. typhi and S. paratyphi A. We recommend that MIC levels of ofloxacin and ceftriaxone should be monitored along with ciprofloxacin in treatment failure cases of enteric fever.
Insights
Multidrug resistance in Salmonella typhi is increasing. This study found rising minimum inhibitory concentrations (MICs) for ciprofloxacin, ofloxacin, and ceftriaxone in Salmonella typhi and S. paratyphi A, potentially explaining treatment failures.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Multidrug resistance in Salmonella typhi is a significant global health concern.
- Treatment failures in enteric fever have been reported with ciprofloxacin, necessitating updated susceptibility data.
Purpose of the Study:
- To determine the antibiotic susceptibility patterns of Salmonella typhi and Salmonella paratyphi A isolated from typhoid bacteremia cases.
- To evaluate the minimum inhibitory concentrations (MICs) of key antibiotics against these pathogens.
Main Methods:
- Disc diffusion and broth dilution methods were employed to test 50 isolates (48 S. typhi, 2 S. paratyphi A).
- Antibiotics tested included ampicillin, chloramphenicol, cotrimoxazole, tetracycline, ciprofloxacin, ofloxacin, cefuroxime, and ceftriaxone.
Main Results:
- 68% of isolates exhibited resistance to ampicillin, chloramphenicol, cotrimoxazole, and tetracycline (ACCOT).
- All strains remained susceptible to fluoroquinolones, cephalosporins, and aminoglycosides via disc diffusion.
- Elevated MICs were observed for ciprofloxacin (28%), ofloxacin (50%), and ceftriaxone (40%), with some strains showing significantly high values.
Conclusions:
- Emergence of high MIC levels for ciprofloxacin, ofloxacin, and ceftriaxone in S. typhi and S. paratyphi A is documented.
- Rising MICs may correlate with treatment failures in enteric fever.
- Continuous monitoring of MIC levels for ofloxacin and ceftriaxone, alongside ciprofloxacin, is recommended for treatment failure cases.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Bacterial Protein Synthesis
Development of Antibiotic Resistance
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
